Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes
Ian Ganly(Memorial Sloan Kettering Cancer Center), Timothy A. Chan(Cleveland Clinic), Yuri E. Nikiforov(University of Pittsburgh Medical Center), Iñigo Landa(Inserm), Martha A. Zeiger(National Institutes of Health), Yiyu Dong(Memorial Sloan Kettering Cancer Center), Nadeem Riaz(Memorial Sloan Kettering Cancer Center), Venkatraman Seshan(Memorial Sloan Kettering Cancer Center), Promita Bose(Memorial Sloan Kettering Cancer Center), Gouri J. Nanjangud(Memorial Sloan Kettering Cancer Center), Shyamprasad Vasudeva Deraje(Memorial Sloan Kettering Cancer Center), Eric J. Sherman, Christopher B. Umbricht(Johns Hopkins University), Electron Kebebew(Stanford University), Kepal N. Patel(NYU Langone Health), James A. Fagin(Memorial Sloan Kettering Cancer Center), Ed Reznik(Icahn School of Medicine at Mount Sinai), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center), Ronald Ghossein(Memorial Sloan Kettering Cancer Center), Stephanie Eng(Memorial Sloan Kettering Cancer Center), Vladimir Makarov(Memorial Sloan Kettering Cancer Center), Fengshen Kuo(Memorial Sloan Kettering Cancer Center)
Cited by 286
Related Papers
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k